top of page


BioStar Capital Elements Image

BioStar Capital’s investment strategy is driven by a deep-seated commitment to improving patient lives and maximizing returns for our investors.

BioStar Capital - Comprehensive Evaluation Icon

Opportunities are then assessed by BioStar Capital’s leadership team and Medical Venture Partners (MVPs), who are experienced medical practitioners, for commercial relevance, potential buyers, capital needs, IP, clinical impact, and value-add opportunities.


BioStar Capital - Proprietary Deal Flow Icon

Investment opportunities come through BioStar Capital’s healthcare connections, many as a direct result of our reputation, track record, access to patients and clinical trials at leading research centers, and assistance in securing FDA approvals.

deal flow

BioStar Capital - Post Investment Involvement Icon

Our team of experts provides additional value to our portfolio companies by supporting the achievement of both clinical and commercial objectives, ultimately guiding them towards a successful exit.

Post investment 

BioStar Capital Elements Image
BioStar Capital Image - Physician

Industry Focus

Given our deep clinical expertise, we focus on innovation in Medtech that addresses unmet patient
needs with an emphasis on Cardiovascular and Orthopedics, both major billion-dollar markets:


  • “Smart” devices & robotics 

  • Minimally invasive solutions

  • Cost-reduction technology

  • Access-improvement technology

  • Outpatient-center technology

bottom of page